股骨头坏死保髋手术治疗研究进展

摘要/Abstract

摘要： 股骨头坏死（ONFH），也称为股骨头缺血性坏死，是由不同病因造成的一种病理状态，包括滥用激素、酗酒、创伤、血管损伤以及一些特发性疾病[1]。股骨头坏死造成了股骨头软骨下骨血供的减少，从而导致了成骨细胞的死亡及关节面的塌陷。股骨头一旦发生塌陷，大部分患者将不可避免的进行髋关节置换手术。但髋关节置换手术并不是每个患者的最佳选择，除了关节假体本身的因素外，部分患者的年龄与疾病特点可能会面临人工关节多次翻修的风险，因而股骨头坏死的保髋治疗更为一些学者所提倡。目前，股骨头坏死的保髋手术治疗主要包括截骨术、髓芯减压术、植骨术、钽棒置入术、干细胞治疗等，本文将从不同机制上对近年来常见的一些保髋手术做一综述。

关键词: 股骨头坏死, 保髋, 手术治疗, 进展

Abstract: Osteonecrosis of the femoral head (ONFH), also known as femoral head avascular necrosis, is a pathological state due to different etiologies, including steroid administration, alcohol abuse, traumatic events, vascular injury and idiopathic origins. ONFH reduces the blood supply of the subchondral bone of the femoral head, which results in osteocyte death and the collapse of the articular surface. Once the collapse happens, the majority of patients inevitably need total hip replacement. But hip replacement surgery is not the best choice for each patient. Expect for the joint prosthesis factors, the patient's age and disease characteristics may result in several renovations. So more and more scholars suggest that we would better reserve the femoral head. Currently, such surgerys include osteotomy, core decompression, bone graft surgery, tantalum rods surgery, stem cell therapy, etc. The aim of the present review is to summarize the hip-reserving surgerys for ONFH by different mechanisms from a new perspective.

Key words: Osteonecrosis of the femoral head, Hip-reserving, Surgerys, Progress

全坤梅炯. 股骨头坏死保髋手术治疗研究进展[J]. 外科研究与新技术, 2016, 5(4): 277-280,286.

参考文献

[1] 赵海燕, 夏亚一, 康鹏德. 股骨头坏死病因与发病机制研究进展[J]. 中国矫形外科杂志, 2009, 8:604 -607.
[2] Cheng W, Jiang P, Shi BL. Summary of the various treatments for osteonecrosis of the femoral head by mechanism: A review[J]. Experimental And Therapeutic Medicine, 2014, 8:700-706.
[3] Sugioka Y. Transtrochanteric anterior rotational osteotomy of the femoral head in the treatment of osteonecrosis affecting the hip: a new osteotomy operation[J]. Clin Orthop Relat Res 1978, 130:191-201.
[4] Moya-Angeler J, Gianakos AL, Villa JC, et al. Current concepts on osteonecrosis of the femoral head[J]. World Journal of Orthopedics, 2015, 6(8):590-601.
[5] Hisatome T, Yasunaga Y, Takahashi K, et al. Progressive collapse of transposed necrotic area after transtrochanteric rotational osteotomy for osteonecrosis of the femoral head induces osteoarthritic change. Mid-term results of transtrochanteric rotational osteotomy for osteonecrosis of the femoral head[J]. Arch Orthop Trauma Surg 2004, 124:77-81.
[6] 孟祥晖, 王万明. 股骨头坏死的保头手术治疗[J]. 中国矫形外科杂志, 2011, 2:308-310.
[7] Okazaki S, Nagoya S, Tateda K, et al. Weight bearing does not contribute to the development of osteonecrosis of the femoral head[J]. Int J Exp Pathol, 2012, 93:458?462.
[8] Tetik C, Ba?ar H, Bezer M, et al. Comparison of early results of vascularized and non?vascularized fibular grafting in the treatment of osteonecrosis of the femoral head[J]. Acta Orthop Traumatol Turc, 2011, 45:326?334.
[9] Seyler TM, Marker DR, Ulrich SD, et al. Nonvascularized bone grafting defers joint arthroplasty in hip osteonecrosis[J]. Clin Orthop Relat Res, 2008, 466:1125?1132.
[10] Rosenwasser MP, Garino JP, Kiernan HA, et al. Long term followup of thorough debridement and cancellous bone grafting of the femoral head for avascular necrosis[J]. Clin Orthop Relat Res, 1994, 306:17?27.
[11] Marciniak D, Furey C, Shaffer JW. Osteonecrosis of the femoral head. A study of 101 hips treated with vascularized fibular grafting[J]. J Bone Joint Surg Am, 2005, 87:742?747.
[12] Sakamoto A, Yoshida T, Uchida Y, et al. Long?term follow?up on the use of vascularized fibular graft for the treatment of congenital pseudarthrosis of the tibia[J]. J Orthop Surg Res, 2008, 3:13.
[13] Liang K, Xiang Z, Chen S, et al. Folded free vascularized fibular grafts for the treatment of subtrochanteric fractures complicated with segmental bone defects[J]. J Trauma Acute Care Surg, 2012, 72:1404?1410.
[14] Watters TS, Browne JA, Orlando LA, et al. Cost?effectiveness analysis of free vascularized fibular grafting for osteonecrosis of the femoral head[J]. J Surg Orthop Adv, 2011, 20:158?167.
[15] Kawate K, Yajima H, Sugimoto K, et al. Indications for free vascularized fibular grafting for the treatment of osteonecrosis of the femoral head[J]. BMC Musculoskelet Disord, 2007, 8:78.
[16] Feng Y, Wang S, Jin D, et al. Free vascularised fibular grafting with OsteoSet?2 demineralised bone matrix versus autograft for large osteonecrotic lesions of the femoral head[J]. Int Orthop, 2011, 35:475?481.
[17] Stronach BM, Duke JN, Rozensweig SD, et al. Subtrochanteric femur fracture after core decompression and placement of a tantalum strut for osteonecrosis of the femoral head[J]. J Arthroplasty, 2010, 25:1168?1168.
[18] Aldegheri R, Taglialavoro G, Berizzi A. The tantalum screw for treating femoral head necrosis: rationale and results[J]. Strategies Trauma Limb Reconstr, 2007, 2:63?68.
[19] Varitimidis SE, Dimitroulias AP, Karachalios TS, et al. Outcome after tantalum rod implantation for treatment of femoral head osteonecrosis: 26 hips followed for an average of 3 years[J]. Acta Orthop, 2009, 80:20?25.
[20]Liu B, Sun W, Yue D, et al. Combined tantalum implant with bone grafting for the treatment of osteonecrosis of the femoral head[J]. J Invest Surg, 2013, 26:158-162.
[21] Shuler MS, Rooks MD, Roberson JR. Porous tantalum implant in early osteonecrosis of the hip: preliminary report on operative, survival, and outcomes results[J]. J Arthroplasty, 2007, 22:26-31.
[22] Veillette CJ, Mehdian H, Schemitsch EH, et al. Survivorship analysis and radiographic outcome following tantalum rod insertion for osteonecrosis of the femoral head[J]. J Bone Joint Surg Am, 2006, 88:48-55.
[23] Al Omran A. Multiple drilling compared with standard core decompression for avascular necrosis of the femoral head in sickle cell disease patients[J]. Arch Orthop Trauma Surg, 2013, 133:609-613.
[24] 康鹏德，裴福兴，张晖等. 股骨头坏死的外科治疗[J]. 中华骨与关节外科杂志，2008，2:149-153.
[25] Zhao D, Cui D, Wang B, et al. Treatment of early stage osteonecrosis of the femoral head with autologous implantation of bone marrow-derived and cultured mesenchymal stem cells[J]. Bone, 2012, 50:325-330.
[26] Sen RK, Tripathy SK, Aggarwal S, et al. Early results of core decompression and autologous bone marrow mononuclear cells instillation in femoral head osteonecrosis: a randomized control study[J]. J Arthroplasty, 2012, 27:679-686.
[27] Cheng W, Yu W, Meng HY, et al. Application of bone marrow mesenchymal stem cells to the treatment of osteonecrosis of the femoral head[J]. Int J Clin Exp Med, 2015, 8(3):3127-3135.
[28] Rastogi S, Sankineani SR, Nag HL, et al. Intralesional autologous mesenchymal stem cells in management of osteonecrosis of femur: a preliminary study[J]. Musculoskelet Surg, 2013, 97:223-228.
[29] Cuervas-Mons M, Narbona J, Laguna R, et al. Autologous concentrated bone marrow graft in the treatment of femoral head avascular necrosis: clinical outcome after two years of follow up in a non-controlled prospective study[J]. Rev Esp Cir Ortop Traumatol, 2013, 57:106-110.
[30] Lim YW, Kim YS, Lee JW, et al. Stem cell implantation for osteonecrosis of the femoral head[J]. Exp Mol Med, 2013, 45:61.
[31] Marker DR, Seyler TM, Ulrich SD, et al. Do modern techniques improve core decompression outcomes for hip osteonecrosis? [J] Clin Orthop Relat Res, 2008, 466:1093?1103.
[32] Rackwitz L, Eden L, Reppenhagen S, et al. Stem cell? and growth factor?based regenerative therapies for avascular necrosis of the femoral head[J]. Stem Cell Res Ther, 2012, 3:7.
[33] Helbig L, Simank HG, Kroeber M, et al. Core decompression combined with implantation of a demineralised bone matrix for non?traumatic osteonecrosis of the femoral head[J]. Arch Orthop Trauma Surg, 2012, 32:1095?1103.
[34] Liu Y, Liu S, Su X. Core decompression and implantation of bone marrow mononuclear cells with porous hydroxylapatite composite filler for the treatment of osteonecrosis of the femoral head[J]. Arch Orthop Trauma Surg, 2013, 133:125?133.
[35] 赵德伟, 崔大平. 股骨头缺血性坏死修复与再造的长期随访观察[J]. 中国矫形外科杂志, 2008, 16(7):481-484.